and Dietrich Knauth
(Reuters) - Pharmaceutical company Mallinckrodt PLC on Thursday won court approval of its reorganization plan, which includes a $1.7 billion settlement of opioid-related litigation, bringing its 16-month bankruptcy close to an end.
U.S. Bankruptcy Judge John Dorsey in Wilmington, Delaware signed off on the plan in a 103-page written decision. In addition to settling thousands of lawsuits accusing it of deceptively marketing its opioids, the plan allows Mallinckrodt to reduce $5.3 billion in debt by $1.3 billion and hands control of the reorganized company to creditors.
CEO Mark Trudeau said in a statement on Thursday that the company is “pleased to have achieved” this milestone. read more
The settlement comes as more than 100,000 Americans are dying each year - from the scourge of drug overdose and Fentanyl laced drugs! Young Americans are dying in record numbers.
Editor, Daily Stock Deals
Symbol |
|
From The Editor of Daily Stock Deals:
For timely, actionable and potentially profitable news and uncensored views:> sign up for FREE in 15 seconds
Keep an eye on this space for major announcements!
Reminder: Free Membership enables immediate access to @TOP10STOCKS a great way to start your trading day.
You may also like these stories:
As of 11:16a ET 05/19/23